 |
|
Are  -Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
We read with great interest the article by Siddiqui et al1 regarding the underutilization of  -blockers during the perioperative period. The authors have evaluated the frequency of perioperative use of -blockers in patients scheduled for open cholecystectomy. They found that 70% of patients eligible for -blockers did not receive these medications during the perioperative period. While there is no doubt about the interest of -blockade in reducing perioperative cardiac events in high-risk patients scheduled for major noncardiac surgery, the advantage of -blockers remains controversial in patients scheduled for intermediate or low-risk surgery. Morbidity and mortality after open cholecystectomy have been studied extensively. One relatively recent study with more than 40 000 patients showed a low risk of cardiac morbidity and mortality (<1%) after this procedure.2
The American College of Cardiology/American Heart Association has recently stated that the randomized trials evaluating medical therapy in noncardiac surgery do not provide enough data to . . . [Full Text of this Article]
AUTHOR INFORMATION
Emmanuel Marret, MD;
Pierre Albaladejo, MD
RELATED ARTICLES
Are -Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?—Reply
Shahid Ahmed, Anita K. Siddiqui, Henri Delbeau, and Joseph Mattana
Arch Intern Med. 2005;165(3):348-349.
EXTRACT
| FULL TEXT
Lack of Physician Concordance With Guidelines on the Perioperative Use of -Blockers
Anita K. Siddiqui, Shahid Ahmed, Henri Delbeau, David Conner, and Joseph Mattana
Arch Intern Med. 2004;164(6):664-667.
ABSTRACT
| FULL TEXT
|
